Cash flow Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Delayed Nyse Other stock markets 01:20:40 16/05/2026 am IST			5-day change	1st Jan Change
159.31 ^USD	+1.96%		-4.22%	-28.63%

11/05	Smith+Nephew Selects Veeva Systems For Unified Quality Management	CI
07/05	Veeva Systems Inc.(NYSE:VEEV) added to S&P 500 Equal Weighted	CI

f3032edb9e7.CgerPs1UpJWOgjkJ0VzLkHH7MqlVTaYahJkPWrvSJnI.TVHOfKky1du5xXBlh2-P4gW3H_MZL8Fv_PN2GMqkQCQzSdpxvSX0_v7EYA

Published financial data: VEEVA SYSTEMS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2022	2023	2024	2025	2026
Revenues	185.08Cr	215.51Cr	236.37Cr	274.66Cr	319.53Cr
Total Revenues	185.08Cr	215.51Cr	236.37Cr	274.66Cr	319.53Cr
Cost of Goods Sold, Total	50Cr	61Cr	68Cr	70Cr	78Cr
Gross Profit	134.71Cr	154.57Cr	168.64Cr	204.7Cr	241.33Cr
Selling General & Admin Expenses, Total	46Cr	57Cr	63Cr	66Cr	70Cr
R&D Expenses	38Cr	52Cr	63Cr	69Cr	77Cr
Other Operating Expenses, Total	84Cr	108.66Cr	125.7Cr	135.05Cr	146.63Cr
Operating Income	51Cr	46Cr	43Cr	70Cr	95Cr
Interest And Investment Income	1.47Cr	4.59Cr	13Cr	21Cr	27Cr
Net Interest Expenses	1.47Cr	4.59Cr	13Cr	21Cr	27Cr
Currency Exchange Gains (Loss)	-7L	6L	1L	-32.74L	15.35L
Other Non Operating Income (Expenses)	-	6L	-	6L	9L
EBT, Excl. Unusual Items	52Cr	51Cr	56Cr	90Cr	121.67Cr
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-72.01L	29.82L	2.48Cr	2.26Cr	84.51L
Legal Settlements	-	-	-	-50L	-3.06Cr
EBT, Incl. Unusual Items	51Cr	51Cr	59Cr	92Cr	119.45Cr
Income Tax Expense	8.49Cr	2.14Cr	6.23Cr	21Cr	29Cr
Earnings From Continuing Operations	43Cr	49Cr	53Cr	71Cr	91Cr
Net Income to Company	43Cr	49Cr	53Cr	71Cr	91Cr
Net Income - (IS)	43Cr	49Cr	53Cr	71Cr	91Cr
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	43Cr	49Cr	53Cr	71Cr	91Cr
Net Income to Common Excl. Extra Items	43Cr	49Cr	53Cr	71Cr	91Cr
Per Share Items
Net EPS - Basic	2.79	3.14	3.27	4.41	5.55
Basic EPS - Continuing Operations	2.79	3.14	3.27	4.41	5.55
Basic Weighted Average Shares Outstanding	15Cr	16Cr	16Cr	16Cr	16Cr
Net EPS - Diluted	2.63	3	3.22	4.32	5.44
Diluted EPS - Continuing Operations	2.63	3	3.22	4.32	5.44
Diluted Weighted Average Shares Outstanding	16Cr	16Cr	16Cr	17Cr	17Cr
Normalized Basic EPS	2.12	2.04	2.19	3.48	4.65
Normalized Diluted EPS	2	1.95	2.15	3.41	4.55
Supplemental Items
EBITDA	53Cr	49Cr	46Cr	74Cr	98Cr
EBITA	52Cr	48Cr	45Cr	72Cr	96Cr
EBIT	51Cr	46Cr	43Cr	70Cr	95Cr
EBITDAR	55Cr	50Cr	48Cr	75Cr	100.2Cr
Total Revenues (As Reported)	185.08Cr	215.51Cr	236.37Cr	274.66Cr	319.53Cr
Effective Tax Rate - (Ratio)	16.58	4.2	10.6	22.32	23.91
Current Domestic Taxes	6.6Cr	14Cr	16Cr	31Cr	20Cr
Current Foreign Taxes	78.37L	85.07L	1.22Cr	1.09Cr	1.59Cr
Total Current Taxes	7.38Cr	15Cr	17Cr	32Cr	22Cr
Deferred Domestic Taxes	28.15L	-12Cr	-10Cr	-11Cr	6.86Cr
Deferred Foreign Taxes	82.64L	-78.24L	-19.84L	-36.69L	-35.47L
Total Deferred Taxes	1.11Cr	-13Cr	-11Cr	-11Cr	6.51Cr
Normalized Net Income	32Cr	32Cr	35Cr	56Cr	76Cr
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	29Cr	35Cr	38Cr	40Cr	43Cr
General and Administrative Expenses	17Cr	22Cr	25Cr	26Cr	27Cr
Research And Development Expense From Footnotes	38Cr	52Cr	63Cr	69Cr	77Cr
Net Rental Expense, Total	1.4Cr	1.6Cr	1.6Cr	1.4Cr	1.7Cr
Stock-Based Comp., COGS (Total)	4.11Cr	5.66Cr	5.97Cr	5.8Cr	6.47Cr
Stock-Based Comp., R&D Exp. (Total)	8.38Cr	14Cr	17Cr	19Cr	20Cr
Stock-Based Comp., S&M Exp. (Total)	5.68Cr	8.75Cr	9.09Cr	9.02Cr	9.74Cr
Stock-Based Comp., G&A Exp. (Total)	5.29Cr	6.62Cr	7.03Cr	10Cr	11Cr
Total Stock-Based Compensation	23Cr	35Cr	39Cr	44Cr	47Cr

Fiscal Period: January	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	113.8Cr	89Cr	70Cr	111.88Cr	142.12Cr
Short Term Investments	123.81Cr	221.62Cr	332.43Cr	403.14Cr	513.96Cr
Total Cash And Short Term Investments	237.61Cr	310.26Cr	402.78Cr	515.02Cr	656.08Cr
Accounts Receivable, Total	69Cr	79Cr	89Cr	105.71Cr	131.03Cr
Total Receivables	69Cr	79Cr	89Cr	105.71Cr	131.03Cr
Prepaid Expenses	3.55Cr	8.15Cr	8.69Cr	10Cr	13Cr
Other Current Assets, Total	12.22L	-	-	-	-
Total Current Assets	310.72Cr	396.93Cr	500.32Cr	630.88Cr	799.76Cr
Gross Property Plant And Equipment	13Cr	14Cr	14Cr	15Cr	18Cr
Accumulated Depreciation	-3.03Cr	-3.21Cr	-3.68Cr	-3.15Cr	-3.37Cr
Net Property Plant And Equipment	10Cr	11Cr	10Cr	12Cr	15Cr
Goodwill	44Cr	44Cr	44Cr	44Cr	44Cr
Other Intangibles, Total	10Cr	8.25Cr	6.3Cr	4.45Cr	3.03Cr
Deferred Tax Assets Long-Term	50.97L	14Cr	23Cr	34Cr	27Cr
Deferred Charges Long-Term	3.31Cr	3.18Cr	2.39Cr	2.64Cr	3Cr
Other Long-Term Assets, Total	2.51Cr	3.9Cr	4.33Cr	5.65Cr	6.23Cr
Total Assets	381.65Cr	480.43Cr	591.09Cr	733.98Cr	897.93Cr
Liabilities
Accounts Payable, Total	2.03Cr	4.17Cr	3.15Cr	3.04Cr	3.76Cr
Accrued Expenses, Total	6.99Cr	7.96Cr	7.64Cr	7.5Cr	9.17Cr
Current Portion of Leases	1.1Cr	1.13Cr	93.34L	99.69L	1.22Cr
Current Income Taxes Payable	77.61L	49.46L	1.19Cr	90.24L	66.98L
Unearned Revenue Current, Total	73Cr	87Cr	104.98Cr	127.4Cr	148.88Cr
Total Current Liabilities	84Cr	100.68Cr	117.89Cr	139.84Cr	163.71Cr
Long-Term Leases	4.36Cr	4.97Cr	4.64Cr	6.58Cr	8.37Cr
Deferred Tax Liability Non Current	22.16L	14.92L	20.52L	6L	6L
Other Non Current Liabilities	1.82Cr	3.01Cr	3.87Cr	4.26Cr	4.33Cr
Total Liabilities	90Cr	108.8Cr	126.61Cr	150.74Cr	176.46Cr
Common Stock, Total	2T	2T	2T	2T	2T
Additional Paid In Capital	119.65Cr	153.26Cr	191.5Cr	238.62Cr	284.31Cr
Retained Earnings	172.7Cr	221.48Cr	274.05Cr	345.46Cr	436.35Cr
Comprehensive Income and Other	-1.2Cr	-3.11Cr	-1.06Cr	-84.16L	81.6L
Total Common Equity	291.16Cr	371.63Cr	464.48Cr	583.24Cr	721.48Cr
Total Equity	291.16Cr	371.63Cr	464.48Cr	583.24Cr	721.48Cr
Total Liabilities And Equity	381.65Cr	480.43Cr	591.09Cr	733.98Cr	897.93Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	15Cr	16Cr	16Cr	16Cr	16Cr
ECS Total Common Shares Outstanding	15Cr	16Cr	16Cr	16Cr	16Cr
Book Value / Share	18.88	23.48	28.8	35.87	44.05
Tangible Book Value	236.98Cr	319.39Cr	414.19Cr	534.8Cr	674.46Cr
Tangible Book Value Per Share	15.37	20.18	25.68	32.89	41.18
Total Debt	5.46Cr	6.1Cr	5.58Cr	7.58Cr	9.59Cr
Net Debt	-232.15Cr	-304.17Cr	-397.2Cr	-507.45Cr	-646.5Cr
Debt Equivalent Oper. Leases	11Cr	13Cr	13Cr	11Cr	14Cr
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	30.4L	30.4L	30.4L	30.4L	30.4L
Buildings, Total	2.1Cr	2.1Cr	2.1Cr	2.1Cr	2.1Cr
Machinery, Total	1.86Cr	1.62Cr	1.8Cr	77.71L	1.04Cr
Full Time Employees	5.48T	6.74T	7.17T	7.29T	7.93T
Accumulated Allowance for Doubtful Accounts (Supple)	5L	5L	5L	57T	3L

Fiscal Period: January	2022	2023	2024	2025	2026
Net Income	43Cr	49Cr	53Cr	71Cr	91Cr
Depreciation & Amortization - CF	84.48L	1.01Cr	1.36Cr	2.04Cr	2.4Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.9Cr	1.9Cr	1.9Cr	1.9Cr	1.4Cr
Depreciation & Amortization, Total	2.74Cr	2.91Cr	3.26Cr	3.94Cr	3.8Cr
Amortization of Deferred Charges, Total - (CF)	2.6Cr	2.21Cr	1.82Cr	1.55Cr	1.64Cr
(Gain) Loss on Sale of Investments - (CF)	62.64L	-36.24L	-2.65Cr	-2.44Cr	-96.93L
Stock-Based Compensation (CF)	23Cr	35Cr	39Cr	44Cr	47Cr
Provision and Write-off of Bad Debts	3L	3L	7L	-	-
Other Operating Activities, Total	2.17Cr	-11Cr	-9.39Cr	-9.95Cr	8.09Cr
Change In Accounts Receivable	-8.31Cr	-9.11Cr	-10Cr	-17Cr	-25Cr
Change In Accounts Payable	-29.97L	2.14Cr	-1.02Cr	-19.61L	60.8L
Change in Unearned Revenues	12Cr	14Cr	19Cr	23Cr	21Cr
Change In Income Taxes	52.75L	-28.15L	69.16L	-28.38L	-23.26L
Change in Other Net Operating Assets	-1.47Cr	-6.07Cr	-2Cr	-4.65Cr	-5.42Cr
Cash from Operations	76Cr	78Cr	91Cr	109.01Cr	141.52Cr
Capital Expenditure	-1.42Cr	-1.35Cr	-2.62Cr	-2.05Cr	-2.91Cr
Cash Acquisitions	-77.8L	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-32Cr	-99Cr	-105.02Cr	-68Cr	-107.52Cr
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-35Cr	-100.77Cr	-107.64Cr	-70Cr	-110.44Cr
Long-Term Debt Repaid, Total	-4L	-	-	-	-
Total Debt Repaid	-4L	-	-	-	-
Issuance of Common Stock	5.15Cr	4.37Cr	6.27Cr	11Cr	25Cr
Repurchase of Common Stock	-5.53Cr	-6.3Cr	-7.89Cr	-7.94Cr	-26Cr
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-41.4L	-1.94Cr	-1.62Cr	2.61Cr	-93.33L
Foreign Exchange Rate Adjustments	-46.57L	-49.86L	-17.8L	-17.35L	9L
Net Change in Cash	41Cr	-25Cr	-18Cr	41Cr	30Cr
Supplemental Items
Cash Income Tax Paid (Refund)	5.86Cr	17Cr	13Cr	32Cr	23Cr
Levered Free Cash Flow	63Cr	71Cr	75Cr	94Cr	104.81Cr
Unlevered Free Cash Flow	63Cr	71Cr	75Cr	94Cr	104.81Cr
Change In Net Working Capital	-4.17Cr	-3.01Cr	-6.53Cr	-3.58Cr	4.18Cr
Net Debt Issued / Repaid	-4L	-	-	-	-

Fiscal Period: January	2022	2023	2024	2025	2026
Profitability
Return on Assets	9.21	6.66	5.01	6.57	7.25
Return on Total Capital	11.93	8.51	6.33	8.21	8.96
Return On Equity %	16.51	14.72	12.58	13.63	13.93
Return on Common Equity	16.51	14.72	12.58	13.63	13.93
Margin Analysis
Gross Profit Margin %	72.79	71.72	71.35	74.53	75.53
SG&A Margin	24.83	26.28	26.57	23.94	21.87
EBITDA Margin %	28.8	22.65	19.54	26.79	30.83
EBITA Margin %	28.34	22.18	18.97	26.05	30.08
EBIT Margin %	27.31	21.3	18.16	25.36	29.64
Income From Continuing Operations Margin %	23.09	22.63	22.24	26	28.44
Net Income Margin %	23.09	22.63	22.24	26	28.44
Net Avail. For Common Margin %	23.09	22.63	22.24	26	28.44
Normalized Net Income Margin	17.54	14.68	14.89	20.52	23.8
Levered Free Cash Flow Margin	34.12	32.79	31.81	34.33	32.8
Unlevered Free Cash Flow Margin	34.12	32.79	31.81	34.33	32.8
Asset Turnover
Asset Turnover	0.54	0.5	0.44	0.41	0.39
Fixed Assets Turnover	17.24	20.59	22.59	24.53	24.06
Receivables Turnover (Average Receivables)	2.83	2.91	2.82	2.82	2.7
Short Term Liquidity
Current Ratio	3.7	3.94	4.24	4.51	4.89
Quick Ratio	3.65	3.86	4.17	4.44	4.81
Operating Cash Flow to Current Liabilities	0.91	0.78	0.77	0.78	0.86
Days Sales Outstanding (Average Receivables)	128.78	125.3	129.23	129.63	135.22
Average Days Payable Outstanding	15.8	18.57	19.72	16.21	15.89
Long Term Solvency
Total Debt/Equity	1.87	1.64	1.2	1.3	1.33
Total Debt / Total Capital	1.84	1.61	1.19	1.28	1.31
LT Debt/Equity	1.5	1.34	1	1.13	1.16
Long-Term Debt / Total Capital	1.47	1.31	0.99	1.11	1.14
Total Liabilities / Total Assets	23.71	22.65	21.42	20.54	19.65
Total Debt / EBITDA	0.1	0.12	0.12	0.1	0.1
Net Debt / EBITDA	-4.24	-6.03	-8.31	-6.77	-6.45
Total Debt / (EBITDA - Capex)	0.1	0.12	0.12	0.1	0.1
Net Debt / (EBITDA - Capex)	-4.36	-6.2	-8.79	-6.96	-6.65
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.33	16.44	9.68	16.2	16.34
Gross Profit, 1 Yr. Growth %	27.55	14.74	9.1	21.38	17.9
EBITDA, 1 Yr. Growth %	30.86	-8.39	-5.38	59.28	33.86
EBITA, 1 Yr. Growth %	31.85	-8.85	-6.22	59.58	34.32
EBIT, 1 Yr. Growth %	33.8	-9.18	-6.48	62.21	35.98
Earnings From Cont. Operations, 1 Yr. Growth %	12.47	14.11	7.79	35.84	27.27
Net Income, 1 Yr. Growth %	12.47	14.11	7.79	35.84	27.27
Normalized Net Income, 1 Yr. Growth %	30.83	-2.58	11.28	60.11	34.92
Diluted EPS Before Extra, 1 Yr. Growth %	11.44	14.07	7.33	34.16	25.93
Accounts Receivable, 1 Yr. Growth %	13.54	13.08	13.16	18.97	23.95
Net Property, Plant and Equip., 1 Yr. Growth %	-5.82	0.98	-0.97	15.02	21.8
Total Assets, 1 Yr. Growth %	25.29	25.88	23.03	24.17	22.34
Tangible Book Value, 1 Yr. Growth %	38.13	34.77	29.68	29.12	26.11
Common Equity, 1 Yr. Growth %	28.47	27.63	24.99	25.57	23.7
Cash From Operations, 1 Yr. Growth %	38.68	2.09	16.77	19.61	29.83
Capital Expenditures, 1 Yr. Growth %	63.7	-4.94	93.87	-21.67	41.97
Levered Free Cash Flow, 1 Yr. Growth %	49.37	11.89	6.41	25.38	11.17
Unlevered Free Cash Flow, 1 Yr. Growth %	49.37	11.89	6.41	25.38	11.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	29.47	21.28	13.01	12.89	16.27
Gross Profit, 2 Yr. CAGR %	29.71	20.97	11.89	15.08	19.63
EBITDA, 2 Yr. CAGR %	31.95	9.49	-6.9	22.77	46.02
EBITA, 2 Yr. CAGR %	33.07	9.63	-7.55	22.33	46.41
EBIT, 2 Yr. CAGR %	32.9	10.24	-7.84	23.17	48.52
Earnings From Cont. Operations, 2 Yr. CAGR %	19.14	13.29	10.91	21.01	31.49
Net Income, 2 Yr. CAGR %	19.14	13.29	10.91	21.01	31.49
Normalized Net Income, 2 Yr. CAGR %	29.31	12.9	4.12	33.48	46.98
Diluted EPS Before Extra, 2 Yr. CAGR %	17.65	12.75	10.65	20	29.98
Accounts Receivable, 2 Yr. CAGR %	28.2	13.31	13.12	16.03	21.44
Net Property, Plant and Equip., 2 Yr. CAGR %	0.12	-2.48	-0	6.73	18.36
Total Assets, 2 Yr. CAGR %	29.61	25.59	24.45	23.6	23.25
Tangible Book Value, 2 Yr. CAGR %	47.28	36.44	32.2	29.4	27.61
Common Equity, 2 Yr. CAGR %	32.22	28.05	26.3	25.28	24.63
Cash From Operations, 2 Yr. CAGR %	32.21	18.99	9.18	18.18	24.62
Capital Expenditures, 2 Yr. CAGR %	81.37	24.75	35.76	23.23	5.45
Levered Free Cash Flow, 2 Yr. CAGR %	30.67	29.28	9.12	15.51	18.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.67	29.28	9.12	15.51	18.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	29	24.97	17.29	14.06	14.03
Gross Profit, 3 Yr. CAGR %	29.73	24.51	16.88	14.97	16.01
EBITDA, 3 Yr. CAGR %	31.02	16.84	4.29	11.35	26.36
EBITA, 3 Yr. CAGR %	31.65	17.3	4.07	10.9	26.2
EBIT, 3 Yr. CAGR %	31.39	17.06	4.36	11.27	27.3
Earnings From Cont. Operations, 3 Yr. CAGR %	22.97	17.44	11.43	18.66	23.06
Net Income, 3 Yr. CAGR %	22.97	17.44	11.43	18.66	23.06
Normalized Net Income, 3 Yr. CAGR %	30.06	17.66	12.36	20.18	33.96
Diluted EPS Before Extra, 3 Yr. CAGR %	21.4	16.45	10.91	17.99	21.94
Accounts Receivable, 3 Yr. CAGR %	29.25	22.95	13.26	15.04	18.61
Net Property, Plant and Equip., 3 Yr. CAGR %	23.74	0.41	-1.98	4.77	11.53
Total Assets, 3 Yr. CAGR %	32.15	28.36	24.73	24.36	23.18
Tangible Book Value, 3 Yr. CAGR %	28.48	42.99	34.15	31.17	28.3
Common Equity, 3 Yr. CAGR %	32.99	30.67	27.02	26.06	24.75
Cash From Operations, 3 Yr. CAGR %	34.98	21.29	18.24	12.55	21.94
Capital Expenditures, 3 Yr. CAGR %	13.12	46.23	44.5	13.02	29.18
Levered Free Cash Flow, 3 Yr. CAGR %	37.98	24.08	21.16	14.29	14.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.98	24.08	21.16	14.29	14.04
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	27.44	25.56	22.35	19.99	16.88
Gross Profit, 5 Yr. CAGR %	29.02	26.4	22.28	20.65	17.97
EBITDA, 5 Yr. CAGR %	31.7	23.17	14.29	19.18	19.32
EBITA, 5 Yr. CAGR %	32.41	23.6	14.29	19.29	19.29
EBIT, 5 Yr. CAGR %	33.17	23.79	14.01	19.46	20.18
Earnings From Cont. Operations, 5 Yr. CAGR %	40.68	26.4	18	18.85	19.06
Net Income, 5 Yr. CAGR %	40.68	26.4	18	18.85	19.06
Normalized Net Income, 5 Yr. CAGR %	33.15	24.75	18.99	23.75	25.1
Diluted EPS Before Extra, 5 Yr. CAGR %	37.76	25.08	16.98	17.85	18.18
Accounts Receivable, 5 Yr. CAGR %	30.59	26.96	22.54	20.13	16.46
Net Property, Plant and Equip., 5 Yr. CAGR %	15.85	15	13.63	2.89	5.7
Total Assets, 5 Yr. CAGR %	32.99	31.32	29.01	26.43	24.14
Tangible Book Value, 5 Yr. CAGR %	35.57	32.61	29.96	37.39	31.49
Common Equity, 5 Yr. CAGR %	34.86	32.61	30.28	28.49	26.06
Cash From Operations, 5 Yr. CAGR %	39.63	27.3	24	20.04	20.75
Capital Expenditures, 5 Yr. CAGR %	15.47	7	21.68	36.56	27.39
Levered Free Cash Flow, 5 Yr. CAGR %	31.76	32.32	25.62	20.58	19.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	31.76	32.32	25.62	20.58	19.91